Clarus Therapeutics reports $3.85 million net loss for October

Chicago, Nov. 22 – Clarus Therapeutics Holdings, Inc. debtor Clarus Therapeutics, Inc. reported a $3.85 million net loss on $1.51 million of gross income/sales for the October period, according to its monthly operating report filed with the U.S. Bankruptcy Court for the District of Delaware.

This compares with $2.81 million net loss on $629,049 of gross income/sales for the September period.

The cash balance at the end of the month was $3.09 million versus $7.67 million at the end of September.

The Northbrook, Ill.-based pharmaceutical company filed bankruptcy under Chapter 11 on Sept. 5. The case number is 22-10845.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.